3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
11
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
6
Stomach Neoplasms
4
Colonic Neoplasms
2
Uterine Cervical Neoplasms
1
Small Cell Lung Carcinoma
1
Recurrence
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Liver Neoplasms
1
Gallbladder Neoplasms
1
Fruquintinib
1
Esophageal Neoplasms
1
Colorectal Cancer Metastatic
1
Carcinoma, Non-Small-Cell Lung
1
Biliary Tract Neoplasms
1
Ampullary Adenocarcinoma
1
Interventions
Immunohistochemistry
3
Observation
2
Biopsy
2
trastuzumab deruxtecan
1
taxane
1
Watchful Waiting
1
Urination
1
Tomography, X-Ray Computed
1
Tegafur
1
Taxes
1
Surveys and Questionnaires
1
S 1 (combination)
1
Radiofrequency Ablation
1
Psychiatric Rehabilitation
1
Polymerase Chain Reaction
1
Platinum Compounds
1
Oxaliplatin
1
Minimally Invasive Surgical Procedures
1
Microbiota
1
Methylation
1
Mass Spectrometry
1
Liquid Biopsy
1
Leucovorin
1
Irinotecan
1
Hyperthermic Intraperitoneal Chemotherapy
1
Gene Expression Profiling
1
Gemcitabine
1
Frozen Sections
1
Fluorouracil
1
Epirubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Gallbladder Neoplasms
×
Irinotecan
×
Clear all
NCT03668418
2018-09-12
xenoZ
University of Pisa
Unknown
120 enrolled